Amarin Corporation plc (AMRN)

1.4200 -0.0200 (-1.39%) At close: 04:00PM EDT

Amarin Corporation plc

Grand Canal Docklands
Block C 77 Sir John Rogerson's Quay
Dublin 2
Ireland
353 1 669 9020
https://www.amarincorp.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 560

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Michael W. Kalb	CFO, Sr. VP & Assistant Sec.	656.66k	N/A	1971
Dr. Steven B. Ketchum Ph.D.	Pres of R&D, Exec. VP and Chief Scientific Officer	758.14k	N/A	1965
Mr. Aaron D. Berg	Exec. VP & Pres of U.S.	656.09k	N/A	1963
Mr. Karim Mikhail	Pres, CEO & Director	N/A	N/A	1971
Ms. Lisa M. DeFrancesco	Sr. VP of Corp. Affairs & Investor Relations	N/A	N/A	1980
Mr. Jason M. Marks J.D.	Exec. VP, Chief Legal and Compliance Officer & Corp. Sec.	N/A	N/A	1976
Alina Kolomeyer	Director of Communications	N/A	N/A	N/A
Mr. Alan J. Wills B.A., BA (Zoology), M.B.A., MBA	Exec. VP of Corp. Bus. Devel.	N/A	N/A	1963
Ms. Donna Pasek	Sr. VP of HR	N/A	N/A	N/A
Dr. Keith Wood	Head of R&D Operations	N/A	N/A	N/A

Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Corporate Governance

Amarin Corporation plc’s ISS Governance QualityScore as of May 1, 2022 is 8. The pillar scores are Audit: 8; Board: 8; Shareholder Rights: 8; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.